Redefining Cancer Research & Treatment
Seven and Eight Biopharmaceuticals Inc. is an experienced biopharmaceutical company committed to discovering and developing new and innovative immunotherapies. Researchers and Clinicians at Seven and Eight Biopharma are using advanced techniques to develop novel therapies to activate the immune system against cancer. Ongoing clinical trials are studying these novel therapies in patients with cancer.
The key to effective immunotherapy treatments is to utilize existing knowledge while investigating new possibilities. Our research is leading us to novel and innovative solutions.
We are leaders in advanced biotechnology research, discoveries and drug development.
Clinical partnership with Merck (MSD) and Roche (Genentech). Solid funding from experienced investors sharing a vision for cancer treatments.
Seven and Eight Biopharma is a clinical stage company dedicated to developing medicines that help cancer patients.
We devote our expertise and resources to explore and enhance the science of immunotherapy.